NCT06644443
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Shenzhen University General Hospital Shenzhen, Guangdong, China
Clinical trial condition
Multiple Myeloma in Relapse
Explore clinical trials studying Multiple Myeloma in Relapse. Study availability and eligibility vary by location and protocol.
57 public trials
23 recruiting studies
Multiple Myeloma in Relapse trial results
NCT04657861
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT04603872
- Conditions
- Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphocytic Leukaemia Refractory, Blood Protein Disorders, +28 more
- Locations
-
- The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China
Not Yet Recruiting
A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma
NCT07735546
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma
NCT07637578
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
- Locations
-
Not specified
Not Yet Recruiting
Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma
NCT07191379
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
Not Yet Recruiting
Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma
NCT07611149
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
Phase I/II Study of SENL103 for Relapsed or Refractory Multiple Myeloma: A Multicenter, Open-Label, Single-Arm Trial.
NCT07421856
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma
NCT06880601
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
- Locations
-
Not specified
Not Yet Recruiting
Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM
NCT05909826
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified